導向抗腫瘤壞死因子-α的單域抗體及為此的用途

• 收藏
• 分享

专利权人:

ABLYNX N.V.

发明人:

SILENCE, KAREN,LAUWEREYS, MARC,DE HAARD, HANS

申请号：

HK05111896.7

公开号：

HK1082745B

申请日:

2005.12.22

申请国别(地区):

HK

年份:

2016

代理人:

摘要：

The invention relates to a method suitable for administering protein therapeutic molecules orally, sublingually, topically, intravenously, subcutaneously, nasally, vaginally, rectally or by inhalation so as to avoid inactivation, by using VHH polypeptides derived from Camelidae antibodies. The invention further relates to the said therapeutic molecules. The invention further relates to a method for delivering therapeutic molecules to the interior of cells. The invention further relates to anti-IgE therapeutic molecules.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/